Latest Breaking News On - Rubius president - Page 1 : comparemela.com

Rubius Therapeutics (RUBY) said it was discontinuing ongoing trials of RTX-240 and RTX-224 for advanced solid tumors and was reducing its workforce by 75%. Rubius is restructuring.

Rhode islandUnited statesPablo cagnoniKlaus vedfeltRed cell therapeuticsRubius president